NO20064298L - Piperazinureaderivater til behandling av endometriose - Google Patents

Piperazinureaderivater til behandling av endometriose

Info

Publication number
NO20064298L
NO20064298L NO20064298A NO20064298A NO20064298L NO 20064298 L NO20064298 L NO 20064298L NO 20064298 A NO20064298 A NO 20064298A NO 20064298 A NO20064298 A NO 20064298A NO 20064298 L NO20064298 L NO 20064298L
Authority
NO
Norway
Prior art keywords
treatment
endometriosis
urea derivatives
piperazine urea
piperazine
Prior art date
Application number
NO20064298A
Other languages
English (en)
Inventor
Richard Horuk
Ulrike Kaufmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20064298L publication Critical patent/NO20064298L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anvendelse av en forbindelse med den påfølgende formel (Ia) for fremstilling av et medikament for behandling av endometriose i mennesker, hvori behandlingen omfatter tilførsel til en kvinne med behov for slik behandling av en terapeutisk effektiv mengde av forbindelsen.
NO20064298A 2004-02-24 2006-09-22 Piperazinureaderivater til behandling av endometriose NO20064298L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04090065 2004-02-24
PCT/EP2005/002036 WO2005079769A2 (en) 2004-02-24 2005-02-23 Piperazine derivatives for the treatment of endometriosis

Publications (1)

Publication Number Publication Date
NO20064298L true NO20064298L (no) 2006-11-24

Family

ID=34878280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064298A NO20064298L (no) 2004-02-24 2006-09-22 Piperazinureaderivater til behandling av endometriose

Country Status (21)

Country Link
US (1) US20080119471A1 (no)
EP (1) EP1727526A2 (no)
JP (1) JP2007523126A (no)
KR (1) KR20070033961A (no)
CN (1) CN101090723A (no)
AR (1) AR048068A1 (no)
AU (1) AU2005215156A1 (no)
BR (1) BRPI0507985A (no)
CA (1) CA2556423A1 (no)
CR (1) CR8584A (no)
EA (1) EA200601514A1 (no)
EC (1) ECSP066836A (no)
GT (1) GT200500032A (no)
IL (1) IL177406A0 (no)
NO (1) NO20064298L (no)
PA (1) PA8624501A1 (no)
PE (1) PE20051129A1 (no)
SV (1) SV2006002017A (no)
TW (1) TW200539882A (no)
WO (1) WO2005079769A2 (no)
ZA (1) ZA200607970B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007001829A1 (es) * 2006-06-23 2008-01-25 Smithkline Beecham Corp P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc.
US8445674B2 (en) * 2009-10-21 2013-05-21 Hoffmann-La Roche Inc Heterocyclyl compounds
WO2011112263A1 (en) 2010-03-11 2011-09-15 New York University AMIDO COMPOUNDS AS RORγt MODULATORS AND USES THEREOF
AP2016009020A0 (en) 2013-07-18 2016-02-29 Novartis Ag Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
BR0312204A (pt) * 2002-06-27 2005-04-26 Schering Ag Antagonista de receptor ccr5 de quinolina substituìda

Also Published As

Publication number Publication date
KR20070033961A (ko) 2007-03-27
US20080119471A1 (en) 2008-05-22
PA8624501A1 (es) 2006-07-03
JP2007523126A (ja) 2007-08-16
EP1727526A2 (en) 2006-12-06
CA2556423A1 (en) 2005-09-01
CR8584A (es) 2007-08-28
AR048068A1 (es) 2006-03-29
GT200500032A (es) 2005-10-31
TW200539882A (en) 2005-12-16
SV2006002017A (es) 2006-05-09
ZA200607970B (en) 2008-12-31
AU2005215156A1 (en) 2005-09-01
IL177406A0 (en) 2006-12-10
PE20051129A1 (es) 2006-02-16
WO2005079769A3 (en) 2007-01-04
WO2005079769A2 (en) 2005-09-01
CN101090723A (zh) 2007-12-19
EA200601514A1 (ru) 2007-02-27
BRPI0507985A (pt) 2007-05-08
ECSP066836A (es) 2006-11-24

Similar Documents

Publication Publication Date Title
NO20085217L (no) Effektive pyrimidinderivater i behandlingen av kreft
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
ECSP066314A (es) Derivados piridilo y su uso como agentes terapéuticos
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
TW200637828A (en) Novel cis-imidazolines
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
BRPI0813244B8 (pt) compostos derivados de pirazinona, composições compreendendo ditos compostos, uso dos compostos no tratamento de doenças de pulmão e composto intermediário
IL197393A (en) History of pyridine-4-ram, containing and using pharmaceutical preparations for the preparation of drugs for the treatment of immune-related diseases
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
TW200638935A (en) Pyridazine derivatives and their use as therapeutic agents
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
UY29963A1 (es) Compuestos terapéuticos: piridinas y pirazinas como andamios
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
GEP20084527B (en) Benzimidazolone compounds having 5-ht4 receptor agonistic activity
SE0401342D0 (sv) Therapeutic compounds
TW200626154A (en) Heterocyclic derivatives and their use as therapeutic agents
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
WO2007046868A3 (en) Thiazolidine derivatives and their uses as therapeutic agents
UA104148C2 (ru) [4-(5-аминометил-2-фторфенил)-пиперидин-1-ил]-[7-фтор-1-(2-метоксиэтил)-4-трифторметокси-1h-индол-3-ил]-метанон как ингибитор триптазы тучных клеток
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2007046867A3 (en) Piperidine derivatives and their uses as therapeutic agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application